Latest Revenue Forecast News

Atturra Limited reported a robust 24% increase in FY25 revenue to $300.6 million, driven by cloud services growth and strategic acquisitions. The company eyes over $384 million revenue in FY26, underpinned by expanding proprietary IP and AI investments.

SKS Technologies has delivered a remarkable 92% revenue surge in FY25, driven by its data centre strategy and traditional business growth, while expanding bank facilities and forecasting $300 million revenue for FY26.

Johns Lyng Group reported a modest 1.8% revenue increase for FY25, driven by strong business-as-usual growth despite a steep decline in catastrophe-related income. The company’s FY26 forecast anticipates continued revenue expansion amid ongoing operational challenges.

Australian Clinical Labs reported robust FY25 financial results with revenue and earnings growth, alongside a strong dividend payout and positive outlook for FY26.

Southern Cross Media Group (SCA) reports a robust FY25 with 5% revenue growth, a surge in digital earnings, and a significant reduction in debt, underpinning a resumed dividend payout.

Codan Limited reported a robust FY25 with 22% revenue growth to $674.2 million and a 27% jump in net profit, driven by organic expansion and strategic acquisitions. The company’s communications and metal detection segments both posted solid gains, setting a confident tone for FY26.

Fisher & Paykel Healthcare has issued strong first half FY26 guidance, forecasting significant revenue and profit growth while navigating new US tariffs. Meanwhile, director Pip Greenwood announces her retirement after eight years on the board.

Etherstack plc has delivered a record half year performance in H1 2025, driven by a landmark multi-year contract with AT&T and surging recurring revenues. The wireless communications specialist is poised for sustained growth across its core markets.

Cleo Diagnostics has launched a health economic study in partnership with EntityRisk and Norstella to support the U.S. market entry of its Ovarian Cancer Pre-Surgical Test, aiming to refine reimbursement strategies and accelerate commercialisation.

AVITA Medical reported a 21% increase in Q2 commercial revenue to $18.4 million and narrowed its net loss, yet faces a reimbursement hurdle that forced a downward revision of full-year guidance. The company highlights clinical progress and strategic board appointments as it navigates payment challenges.

Duratec Limited has acquired EIG Australia for up to $9 million, significantly boosting its fuel infrastructure and electrical services capabilities across key Australian sectors including Defence and Mining.

TZ Limited has landed a significant bulk order from Microsoft and completed the Keyvision acquisition, positioning itself for a strong FY26 despite recent US market challenges.